Advertisement
UK markets closed
  • FTSE 100

    8,146.86
    -16.81 (-0.21%)
     
  • FTSE 250

    20,120.36
    -75.59 (-0.37%)
     
  • AIM

    776.04
    -4.39 (-0.56%)
     
  • GBP/EUR

    1.1845
    -0.0034 (-0.29%)
     
  • GBP/USD

    1.2686
    -0.0075 (-0.59%)
     
  • Bitcoin GBP

    52,298.64
    -363.07 (-0.69%)
     
  • CMC Crypto 200

    1,401.47
    -16.40 (-1.16%)
     
  • S&P 500

    5,431.60
    -2.14 (-0.04%)
     
  • DOW

    38,589.16
    -57.94 (-0.15%)
     
  • CRUDE OIL

    78.49
    -0.13 (-0.17%)
     
  • GOLD FUTURES

    2,348.40
    +30.40 (+1.31%)
     
  • NIKKEI 225

    38,814.56
    +94.09 (+0.24%)
     
  • HANG SENG

    17,941.78
    -170.85 (-0.94%)
     
  • DAX

    18,002.02
    -263.66 (-1.44%)
     
  • CAC 40

    7,503.27
    -204.75 (-2.66%)
     

Want Rising Passive Income? Consider These 2 Stocks for Your Portfolio

Want Rising Passive Income? Consider These 2 Stocks for Your Portfolio

Serving more than 100 million customers through its pharmacy benefit manager CVS Caremark and managed care company Aetna, CVS Health (NYSE: CVS) is a company critical to the healthcare sector. It's a safe bet that as long as there is still a need for prescriptions and health insurance, the company will likely do well for its shareholders. This is why analysts believe that CVS Health's non-GAAP (generally accepted accounting principles) adjusted diluted earnings per share (EPS) will compound by 5.9% annually over the next five years.